Yun S. Tang

The Jockey Club School Of Public Health And Primary Care
Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS-CoV-2 Omicron Variants.

Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS-CoV-2 Omicron Variants.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 11, 2026

Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.

Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.

Journal: Vaccine

Published: December 12, 2025

Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germline.

Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germline.

Journal: Cell host & microbe

Published: June 23, 2025

Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity.

Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity.

Journal: Nature communications

Published: April 11, 2025

ISG-15, beyond its functions in the cell: a mini review.

ISG-15, beyond its functions in the cell: a mini review.

Journal: Cellular and molecular life sciences : CMLS

Published: September 10, 2024

Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.

Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.

Journal: The Journal of infection

Published: July 17, 2024

Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.

Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 03, 2024

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.

Journal: Virology journal

Published: February 14, 2024

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.

Journal: Emerging infectious diseases

Published: January 03, 2024

Showing 1-9 of 9

Last Updated: 09/26/2026